1-12 of 12
Laura Michaelis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2, open-label study of the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of DISC-3405 in participants with polycythemia vera (PV)

Free
Naseema Gangat, Ayalew Tefferi, Aaron Gerds, Michael Grunwald, Anna Halpern, Laura Michaelis, Stephen Oh, Caitlin O'Neill, Jeanne Palmer, Kristen Pettit, Lindsay Rein, Candido Rivera, Gary Schiller, Joseph Shatzel, Lisa Guiducci, Jennifer Vaughn, Anne Wofford, Marcus Carden, Will Savage, Prithviraj Bose, Naveen Pemmaraju
Journal: Blood
Blood (2025) 146 (Supplement 1): 2053.
https://doi.org/10.1182/blood-2025-2053
Published: 2025
Journal Articles

RALLY MF: A phase 2 Study of DISC-0974, an anti-hemojuvelin antibody, in patients with myelofibrosis and anemia

Free
Naseema Gangat, Ayalew Tefferi, Prithviraj Bose, Elizabeth Hexner, Laura Michaelis, Aaron Gerds, Akriti Jain, Prioty Islam, Raajit Rampal, Ronan Swords, Moshe Talpaz, Kristen Pettit, Sima Bhatt, Akshay Buch, Olivia Pelletier, Will Savage, Anna Halpern
Journal: Blood
Blood (2025) 146 (Supplement 1): 2042.
https://doi.org/10.1182/blood-2025-2042
Published: 2025
Journal Articles

A multimodal machine learning framework to predict treatment duration in multiple myeloma patients

Free
Frederick Shi, Xinyi Yang, Juan Li, Shijing Wang, Bin Sun, Jing Dong, Peiman Hematti, Siegfried Janz, Anita D'Souza, Laura Michaelis, Binod Dhakal, Fumou Sun
Journal: Blood
Blood (2025) 146 (Supplement 1): 5715.
https://doi.org/10.1182/blood-2025-5715
Published: 2025
Journal Articles

A randomized Phase II trial of ASTX727 and venetoclax with or without enasidenib for newly diagnosed older adults with IDH2 mutant Acute Myeloid Leukemia: A myelomatch substudy (MM1OA-S03)

Free
Eric Huselton, Uma Borate, John Reagan, Richard Little, Steven Gore, Megan Othus, Anna Moseley, Manu Pandey, Xin Wang, Laura Michaelis, Geoffrey Uy, Anjali Advani, Harry Erba
Journal: Blood
Blood (2025) 146 (Supplement 1): 3466.
https://doi.org/10.1182/blood-2025-3466
Published: 2025
Journal Articles

The predictive value of the interleukin 2 receptor (IL2)/ferritin ratio in the diagnosis of lymphoma associated hemophagocytic lymphohistiocytosis (LAHS): A United States, multi center experience

Free
Dariusz Uczkowski, Linzi Hobbs-Parker, Stephanie Yohay, Adarsh Ettyreddy, Natalia Gontarczyk Uczkowski, Chenyu Lin, Alexander Coltoff, Laura Michaelis, Lisa Baumann Kreuziger, Nirav Shah, Ehab Atallah
Journal: Blood
Blood (2025) 146 (Supplement 1): 4769.
https://doi.org/10.1182/blood-2025-4769
Published: 2025
Journal Articles

Cladribine based salvage chemotherapy in AML patients with persistent or recurrent disease after venetoclax/HMA

Free
Sameem Abedin, Guru Subramanian Guru Murthy, Karen-Sue Carlson, Lyndsey Runaas, Walter Longo, Laura Michaelis, Ehab Atallah
Journal: Blood
Blood (2025) 146 (Supplement 1): 5238.
https://doi.org/10.1182/blood-2025-5238
Published: 2025
Journal Articles

Myeloid malignancies molecular analysis for therapy choice (myeloMATCH): Rapid availability of clinical, pathologic and molecular features for treatment assignment in the first 550 patients.

Free
Eric Winer, Megan Othus, Ehab Atallah, Stephanie Tsai, Mitchell Sabloff, Afaf Osman, Annie Im, Sanam Loghavi, Anna Moseley, Brent Wood, Min Fang, Cecilia Yeung, Xueyan Chen, Xiaoyu QU, Lyndsay Harris, Sayak Ghatak, Steven Gore, Geoffrey Uy, Laura Michaelis, Olatoyosi Odenike, Richard Stone, Selina Luger, Sarit Assouline, Harry Erba, Mark Litzow, Curtis Lachowiez, John Reagan, Uma Borate, Mary Lynn Savoie, Brian Jonas, Ntasha Roy, Jerald Radich, Richard Little, Shahanawaz Jiwani
Journal: Blood
Blood (2025) 146 (Supplement 1): 5279.
https://doi.org/10.1182/blood-2025-5279
Published: 2025
Journal Articles

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Free
Clinical Trials & Observations
Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani, John E. Godwin, Martha L. Arellano, Kendra L. Sweet, Ashkan Emadi, Farhad Ravandi, Harry P. Erba, Michael Byrne, Laura Michaelis, Max S. Topp, Norbert Vey, Fabio Ciceri, Matteo Giovanni Carrabba, Stefania Paolini, Gerwin A. Huls, Mojca Jongen-Lavrencic, Martin Wermke, Patrice Chevallier, Emmanuel Gyan, Christian Récher, Patrick J. Stiff, Kristen M. Pettit, Bob Löwenberg, Sarah E. Church, Erica Anderson, Jayakumar Vadakekolathu, Marianne Santaguida, Michael P. Rettig, John Muth, Teia Curtis, Erin Fehr, Kuo Guo, Jian Zhao, Ouiam Bakkacha, Kenneth Jacobs, Kathy Tran, Patrick Kaminker, Maya Kostova, Ezio Bonvini, Roland B. Walter, Jan K. Davidson-Moncada, Sergio Rutella, John F. DiPersio
Journal: Blood
Blood (2021) 137 (6): 751–762.
https://doi.org/10.1182/blood.2020007732
Published: 2021
Includes: Supplemental data
Journal Articles

Title: Promoter Methylation of Selected Genes and Response to Azacitidine (AZ) Therapy in Patients with Non-BCR-ABL Myeloproliferative Disorders (MPDs)

Free
Nicholas Achille, BS, Laura Michaelis, MD, Scott E. Smith, MD, PhD, FACP, Eliza Germano, Nancy J. Zeleznik-Le, PhD, Sucha Nand, MD
Journal: Blood
Blood (2011) 118 (21): 4625.
https://doi.org/10.1182/blood.V118.21.4625.4625
Published: 2011
Journal Articles

Rearrangements of the MLL Gene Are Influenced by DNA Secondary Structure, Potentially Mediated by Topoisomerase II Binding

Free
Hongan Le, Sabine Schnyder, MD, Nga Du, Grace Loredo, Ph.D, Sheetal Singh, Ph.D, Shyh-Jen Shih, Ph.D, Laura Michaelis, MD, Christine Bien, Manuel Diaz, MD, Andrew T.M. Vaughan, PhD
Journal: Blood
Blood (2008) 112 (11): 3105.
https://doi.org/10.1182/blood.V112.11.3105.3105
Published: 2008
Journal Articles

A Randomized Phase IIa Study of Vorinostat in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes: Preliminary Results

Free
Guillermo Garcia-Manero, MD, Lewis B. Silverman, MD, Ivana Gojo, MD, Laura Michaelis, MD, Simrit Parmar, Stuart L Goldberg, Hagop M. Kantarjian, Jose Garcia-Vargas, Syed Rizvi, Karl Heath, Azra Raza
Journal: Blood
Blood (2008) 112 (11): 5084.
https://doi.org/10.1182/blood.V112.11.5084.5084
Published: 2008
Journal Articles

Alemtuzumab (Campath 1-H) Exposure Correlates with Risk of Chronic Graft vs Host Disease and CMV Viremia after Allogeneic Transplantation.

Free
Justin P. Kline, MD, Rajiv Swamy, MD, Dezheng Huo, Laura Michaelis, MD, Richard A. Larson, MD, Elizabeth Rich, MD, PhD, Wendy Stock, MD, Jody Ulaszek, MS, Amittha Wickrema, PhD, Andrew Artz, MD, Maher Albitar, MD, Koen van Besien, MD
Journal: Blood
Blood (2005) 106 (11): 1818.
https://doi.org/10.1182/blood.V106.11.1818.1818
Published: 2005